Putnam Investments’s Enfusion, Inc. ENFN Stock Holding History

Putnam Investments’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,053	Closed	-$404K	–	1236
2023 Q3	$404K	Sell	45,053 -389	-0.9%	-$3.69K	﹤0.01%	958
2023 Q2	$510K	Buy	45,442 +7,679	+20%	+$68.1K	﹤0.01%	921
2023 Q1	$397K	Sell	37,763 -1,586	-4%	-$17.5K	﹤0.01%	991
2022 Q4	$381K	Buy	39,349 +6,836	+21%	+$77K	﹤0.01%	1004
2022 Q3	$401K	Buy	+32,513	New	+$397K	﹤0.01%	983

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Putnam Investments's ENFN Position: Q4 2023 in Review

Putnam Investments sold out of Enfusion, Inc. (ENFN) in Q4 2023, closing a stake of 45,053 shares — an estimated $404K sold.

Putnam Investments first reported a position in ENFN in Q3 2022 and held it in 5 quarters. The position peaked at $510K in Q2 2023. 76 funds tracked by Wall St. Rank hold ENFN as of Q4 2023.

Putnam Investments reported no remaining Enfusion, Inc. position as of Q4 2023 after selling out during the quarter.
Putnam Investments sold 45,053 Enfusion, Inc. shares in Q4 2023, an estimated $404K.
Putnam Investments first reported a position in Enfusion, Inc. in Q3 2022 and held it in 5 quarters.
Putnam Investments's Enfusion, Inc. position peaked at $510K in Q2 2023.
76 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.